A recent phase 2 study revealed that the gel could act positively in microcystic lymphatic malformations, which currently have no FDA-approved treatments available.
The occurrence of immune-mediated inflammatory diseases (IMID) is higher in patients with inflammatory bowel disease (IBD) than in the general population.
A healthy 14-year old boy was evaluated for an intensely pruritic shin rash that developed 2 weeks prior and had been treated with oral antibiotics for 10 days.